A Prospective Study to Evaluate the Safety of a New Trivalent Intranasal Influenza Vaccine
Clinical trial NCT00677820 · COMPLETED
Trial details
- NCT number
- NCT00677820
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2008-07-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.